Hypertension Clinical Trial
— TAP-HC-DMOfficial title:
Teams Advancing Patient Experience: Strengthening Quality for People Through Health Connectors for Diabetes Management (TAPESTRY-HC-DM): A Feasibility RCT
Verified date | October 2017 |
Source | McMaster University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The TAPESTRY-HC-DM approach is designed to support self-management of chronic disease by strengthening connections between patients and the primary healthcare system through "health connectors" -both volunteers and technology including the TAPESTRY Healthy Lifestyle App and McMaster Personal Health Record (PHR). It will explore whether strengthening primary care connections across patients, providers, and community organizations through TAPESTRY-HC-DM - i.e., the deployment of volunteer health connectors coordinated by a community organization, the use of the TAPESTRY Healthy Lifestyle e-Application by patients, and care coordination processes by the interprofessional primary healthcare team - can increase self-efficacy in managing chronic conditions.
Status | Completed |
Enrollment | 50 |
Est. completion date | September 26, 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Active patient at McMaster Family Health Team - Aged 18+ - Diagnosis of Diabetes - Diagnosis of Hypertension - Regular access to a computer And at least ONE of: - Uncontrolled HbA1C measures (in the past 6 months, or most recent) - 10 - Uncontrolled recent blood pressure (in the past 3 months, or most recent) - 140/90 or higher (either number higher) - Newly diagnosed with diabetes (diagnosed within 6 months) - End-stage organ damage/other complications of diabetes [e.g. renal dysfunction, diabetic neuropathy] - Doctor Recommendation Exclusion Criteria: - identified as deceased - explicitly stated they do not want to be part of a research project - reside in long-term care - are receiving end-of-life care - directly related to anyone from the McMaster University Department of Family Medicine - not a participant in another TAPESTRY project |
Country | Name | City | State |
---|---|---|---|
Canada | McMaster Family Health Practice | Hamilton | Ontario |
Canada | McMaster University Department of Family Medicine | Hamilton | Ontario |
Canada | Stonechurch Family Health Centre | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster University | Health Canada, INSPIRE-PHC, McMaster Family Health Team, Ontario Ministry of Health and Long Term Care, Volunteer Hamilton |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diabetes self-efficacy | This is the primary outcome which will be measured by Stanford Diabetes Self-Efficacy Scale, an 8-item scale. | 4-month | |
Secondary | Self-efficacy in Managing General Chronic Conditions | The outcome will be measured by a 6-item Stanford Self-Efficacy Scale for Managing Chronic Disease. It covers several domains that are common across many chronic diseases, symptom control, role function, emotional functioning and communicating with physicians. | 4-month | |
Secondary | Attainment of Health Goals | The outcome will be assessed using a Goal Attainment Scale (GAS) Questionnaire | 4-month | |
Secondary | Assessment of Care for Chronic Conditions | The outcome will be assessed using Assessment of Care for Chronic Conditions survey having 20 items | 4-month | |
Secondary | Patient Empowerment | The outcome will be assessed using Patient Empowerment questionnaire, a 5-item survey questionnaire and Canadian Institutes of Health Research (CIHR) Common Indicator for the Community- Based Primary Health Care (CBPHC) | 4-month | |
Secondary | Patient Centredness | The outcome will be assessed using Patient Centeredness questionnaire, a 6-item questionnaire and CIHR Common Indicator for the Community- Based Primary Health Care (CBPHC) | 4-month | |
Secondary | Satisfaction with Healthcare | This will be measured using a one item questionnaire that inquires how clients would like to rate the quality of healthcare they received on a scale of 0-100 (0=not satisfied, 100=completely satisfied) | 4-month | |
Secondary | Patient Activation | This will be assessed by a 13-item Patient Activation Measure (PAM) questionnaire. | 4-month | |
Secondary | Patient Readiness for Change | Readiness-for-Change Questionnaire (RCQ) for Diabetes Self-Management will be used to examine the clients' stage of readiness for diabetes management behaviour change (pre-contemplation, contemplation, action, maintenance), developed based on the Cardiovascular Risk Reduction Program Readiness-to-Change Lifestyle Behavior | 4-month | |
Secondary | Physical Activity | This will be assessed using the Rapid Assessment of Physical Activity (RAPA). | 4-month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |